Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2016 May 12:5:F1000 Faculty Rev-876.
doi: 10.12688/f1000research.7819.1. eCollection 2016.

Intracerebral haemorrhage in Down syndrome: protected or predisposed?

Affiliations
Review

Intracerebral haemorrhage in Down syndrome: protected or predisposed?

Lewis Buss et al. F1000Res. .

Abstract

Down syndrome (DS), which arises from trisomy of chromosome 21, is associated with deposition of large amounts of amyloid within the central nervous system. Amyloid accumulates in two compartments: as plaques within the brain parenchyma and in vessel walls of the cerebral microvasculature. The parenchymal plaque amyloid is thought to result in an early onset Alzheimer's disease (AD) dementia, a phenomenon so common amongst people with DS that it could be considered a defining feature of the condition. The amyloid precursor protein ( APP) gene lies on chromosome 21 and its presence in three copies in DS is thought to largely drive the early onset AD. In contrast, intracerebral haemorrhage (ICH), the main clinical consequence of vascular amyloidosis, is a more poorly defined feature of DS. We review recent epidemiological data on stroke (including haemorrhagic stroke) in order to make comparisons with a rare form of familial AD due to duplication (i.e. having three copies) of the APP region on chromosome 21, here called 'dup-APP', which is associated with more frequent and severe ICH. We conclude that although people with DS are at increased risk of ICH, this is less common than in dup-APP, suggesting the presence of mechanisms that act protectively. We review these mechanisms and consider comparative research into DS and dup-APP that may yield further pathophysiological insight.

Keywords: Alzheimer’s disease; Cerebral amyloid angiopathy; Down syndrome; Intracerebral haemorrhage; trisomy.

PubMed Disclaimer

Conflict of interest statement

Competing interests: André Strydom has acted as an investigator in clinical trials of medications for Down syndrome sponsored by Roche Pharmaceuticals.

No competing interests were disclosed.

Figures

Figure 1.
Figure 1.. Summary of kindreds harbouring duplication (i.e. having three copies) of the amyloid precursor protein region on chromosome 21 (dup-APP).
Phenotype with respect to dementia (black crescent) and intracerebral haemorrhage (ICH) (red crescent) is shown. Genotype is reported as APP duplication present (dup), absent (-), or not determined (ND). The French kindreds (Wallon et al. ) are not shown, as there are insufficient data provided for this purpose. Owing to limitations of the original article, it was not possible to report the genotypes for the Finnish kindred: nine of the affected individuals carry dup-APP, but it is not reported which of the family members this applies to.
Figure 2.
Figure 2.. Histological severity of cerebral amyloid angiopathy (system of Vonsattel et al. ) seen in post mortem studies of people with Down syndrome in different age groups.
Age ranges are indicated above charts. Data are reproduced from .

Similar articles

Cited by

References

    1. Holland AJ, Hon J, Huppert FA, et al. : Incidence and course of dementia in people with Down's syndrome: findings from a population-based study. J Intellect Disabil Res. 2000;44(Pt 2):138–46. 10.1046/j.1365-2788.2000.00263.x - DOI - PubMed
    1. Vinters HV, Gilbert JJ: Cerebral amyloid angiopathy: incidence and complications in the aging brain. II. The distribution of amyloid vascular changes. Stroke. 1983;14(6):924–8. 10.1161/01.STR.14.6.924 - DOI - PubMed
    1. Pezzini A, Del Zotto E, Volonghi I, et al. : Cerebral amyloid angiopathy: a common cause of cerebral hemorrhage. Curr Med Chem. 2009;16(20):2498–513. 10.2174/092986709788682047 - DOI - PubMed
    1. Knudsen KA, Rosand J, Karluk D, et al. : Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology. 2001;56(4):537–9. 10.1212/WNL.56.4.537 - DOI - PubMed
    1. Mann DM: Cerebral amyloidosis, ageing and Alzheimer's disease; a contribution from studies on Down's syndrome. Neurobiol Aging. 1989;10(5):397–9; discussion 412–4. 10.1016/0197-4580(89)90073-0 - DOI - PubMed

LinkOut - more resources